Evome Medical Technologies (Evome Medical Technologies) Equity-to-Asset : 0.08 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Evome Medical Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2.98 Mil. Evome Medical Technologies's Total Assets for the quarter that ended in Dec. 2023 was $35.97 Mil. Therefore, Evome Medical Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.08.

The historical rank and industry rank for Evome Medical Technologies's Equity-to-Asset or its related term are showing as below:

LNDZF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.08 Med: 0.89 Max: 0.99
Current: 0.08

During the past 11 years, the highest Equity to Asset Ratio of Evome Medical Technologies was 0.99. The lowest was 0.08. And the median was 0.89.

LNDZF's Equity-to-Asset is ranked worse than
91.29% of 873 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs LNDZF: 0.08

Evome Medical Technologies Equity-to-Asset Historical Data

The historical data trend for Evome Medical Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Equity-to-Asset Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.97

0.98

0.51

0.31

0.08

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															0.30	0.27	0.23	0.29	0.08

Competitive Comparison of Evome Medical Technologies's Equity-to-Asset

For the Medical Devices subindustry, Evome Medical Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evome Medical Technologies's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's Equity-to-Asset falls into.

Evome Medical Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Evome Medical Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2.984	/	35.97
	=	0.08

Evome Medical Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	2.984	/	35.97
	=	0.08

Evome Medical Technologies (OTCPK:LNDZF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Evome Medical Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.